SIGN UP FOR OUR NEW NEWSLETTER ABOUT BOSTON AREA LIFE SCIENCES. Subscribe now.
- First Opinion 1 in 5 rural hospitals are at risk of imminent closure. Lawmakers could help some stay open
- First Opinion Ending drug rebates will increase Medicare Part D premiums. Most seniors will be insulated from it
- Health With one manufacturer and little money to be made, supplies of a critical cancer drug are dwindling
- Business Unsealed testimony reveals a goal of Atul Gawande venture: ‘Make health insurance intelligible’
- Health The psychiatry field is buzzing with anticipation — and hesitation — about esketamine for depression
Exclusive analysis of biotech, pharma, and the life sciences
Daily, market-moving coverage of biotech and pharma
Inside intelligence on the NIH, the FDA, and Congress
Profiles of the power players shaping the industry
Analysis of the latest scientific developments
Start your free trial!